Hold CVX through chop — structural floor intact but Q2 contamination debate and distribution event warrant neutral positioning into Oct 31 catalyst
Hold CVX around $204-208. The structural uptrend (50 SMA leading 200 SMA by ~$18, 6.3% total shareholder yield, 37-year Aristocrat streak, 0.52 beta) is intact and argues against trimming, but the TTM P/E at 19.87, September 18 distribution event (47.3M shares, 5-6x normal volume), and Q2 EPS contamination ($2.76B non-recurring Other Income Expense) argue against adding without confirmation. Reinvest the 3.44% dividend. Hard stop at $190 monthly close. Let Q3 earnings on Oct 31 resolve the debate before shifting from Hold.
| Position | Action |
|---|---|
| ATR-adjusted allocation | 75-80% of standard integrated-energy allocation, not 100% — macro and earnings uncertainty argue for smaller end of range |
| Overweight | Trim 25-30% of position at $200-$205 trim trigger |
| Underweight | Re-upgrade to Overweight on confirmed $208+ reclaim with positive MACD and RSI >55, or post-Q3 earnings validation |
Chevron is a screaming buy during a healthy technical consolidation, with generational Q2 2026 fundamentals, 6.3% total shareholder yield, fortress balance sheet metrics, and asymmetric upside macro catalysts — making a HOLD recommendation equivalent to leaving money on the table.
| Indicator | Value | Signal |
|---|---|---|
| close | 206.47 | neutral |
| open | 206.83 | neutral |
| high | 207.23 | neutral |
| low | 201.96 | neutral |
| volume | 6,403,501 | neutral |
| close_10_ema | 206.34 | neutral |
| close_50_sma | 202.21 | bullish |
| close_200_sma | 184.45 | bullish |
| rsi | 51.51 | neutral |
| macd | 0.62 | neutral |
| macds (signal) | 1.36 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Price touch at $200-$202 + MACD histogram compression toward zero + RSI <45 curling up
Then: Add/Scale-in at $200-$202; do not add above $205 absent confirmation
EV: +11.4% (to $230 target)
Chevron is a generational trap at $206 because the stock is priced for a non-repeating Q2 2026 outlier quarter, has unsustainable capital return coverage, and faces asymmetric downside risk with a fair value of $175–$195 based on 13x normalized EPS of $11–13.
EV: -3.0% · concedes: Oil could spike on Iran tail risk, Q3 could beat, and CVX could breakout to $230 (20% probability); The 200-SMA uptrend and monthly price momentum suggest shorting into strength is a fool's errand; At $175–$185, the risk/reward actually works for a re-entry
→ vs conservative: TTM P/E scare is backward-looking math on forward-looking story; trim into strengthening macro leaves money on table
→ vs conservative: Q2 2.76B Other Income Expense flagged as contamination but Guyana ramp, Permian growth, and refining margins are structural
→ vs conservative: Stop at 190 surrenders 7% on 0.52 beta name; 3.5 sigma event threshold means stop cedes ground unnecessarily
→ vs conservative: High-volume red bar followed by quiet grinding is institutional accumulation pattern, not distribution
→ vs conservative: 3.44% yield plus 3% buybacks equals 6.3% total yield; trimming loses compounding benefit that beats 80% of S&P 500
→ vs conservative: 37-year dividend growth streak signals operational discipline; companies don't break such track records casually
→ vs neutral: Fair value ranges are anchored to past; forward EPS inflecting 40% should expand multiple, not compress it
→ vs neutral: Macro itself is the catalyst—oil tape coiled for move given Iran option, OPEC cohesion, and Fed hold
→ vs neutral: Waiting for 'fresh signal' surrenders 6.3% annual yield while compounding occurs in favor of position
→ vs neutral: MACD still positive, RSI neutral at 51, histogram only minus 0.74—not broken technicals
| macdh (histogram) | −0.74 | bearish |
| boll_mid | 208.49 | neutral |
| boll_ub | 216.97 | neutral |
| boll_lb | 200.02 | neutral |
| atr | 4.17 | neutral |
| vwma | 207.31 | neutral |
Support: 202.21 · 200.02 · 184.45 | Resistance: 208.49 · 216.97 · 217.77
CVX is in a confirmed long-term uptrend ($206.47 price, +11.95% above 200 SMA at $184.45) that has entered short-term consolidation after the September 15, 2026 high of $217.77. The 50 SMA ($202.21) sits $17.76 above the 200 SMA ($184.45) with price +2.1% above the 50 SMA, while the 10 EMA ($206.34) is flat against close indicating indecision. MACD shows bearish crossover (line 0.62 below signal 1.36) with negative histogram (−0.74), RSI is neutral at 51.51, and VWMA declined from ~$211.15 to $207.31 suggesting distribution bias. Strong support cluster near $200–$202 (50 SMA and Bollinger lower band confluence), with resistance at $208.49 (BB mid), $216.97 (BB upper), and $217.77 (swing high). Recommended stance: HOLD existing longs; WAIT for new entries.
Market Cap
$405.0 B
Share Price (Implied)
~$206.50
52-Week Range
$146.49 – $217.78
P/E (TTM)
19.87
Forward P/E
14.20
PEG Ratio
0.91
Price / Book
2.13
EPS (TTM)
$10.39
Forward EPS
$14.54
Dividend Yield
3.44%
Beta
0.523
50-Day MA
$202.55
200-Day MA
$186.64
Revenue (TTM)
$209.4 B
EBITDA (TTM)
$50.7 B
Net Income (TTM)
$20.6 B
Operating Margin
21.87%
Net Profit Margin
9.83%
ROE
12.23%
ROA
5.86%
Debt / Equity
18.96
Current Ratio
1.25
FCF (TTM)
$21.93 B
Dividends Paid (TTM)
~$13.9 B
Buybacks (TTM)
~$11.4 B
Total Shareholder Yield
~6.3%
Q2 2026 Revenue
$67.2 B
Q2 2026 Net Income
$12.07 B
Q2 2026 Diluted EPS
$6.11
Q2 2026 Operating Income
$14.28 B
Q2 2026 EBITDA
$23.0 B
Q1 2026 Revenue
$47.56 B
Q1 2026 Net Income
$2.21 B
Q1 2026 Diluted EPS
$1.11
2025 Annual Revenue
$184.43 B
2025 Operating Income
$16.67 B
2025 Net Income
$12.30 B
2025 Diluted EPS
$6.63
2024 Annual Revenue
$193.41 B
2024 Net Income
$17.66 B
2024 Diluted EPS
$9.72
2023 Annual Revenue
$196.91 B
2023 Net Income
$21.37 B
2023 Diluted EPS
$11.36
2022 Annual Revenue
$235.72 B
2022 Net Income
$35.47 B
2022 Diluted EPS
$18.28
Total Assets (Q2 2026)
$330.14 B
Net PPE
$215.94 B
Cash & ST Investments
$8.53 B
Total Debt
$37.08 B
Net Debt
$28.55 B
Stockholders' Equity
$189.88 B
Working Capital
$9.90 B
2025 FCF
$16.59 B
2024 FCF
$15.04 B
2023 FCF
$19.78 B
2022 FCF
$37.63 B
2025 CapEx
$17.35 B
2024 CapEx
$16.45 B
2023 CapEx
$15.83 B
2022 CapEx
$11.97 B
2025 Dividends Paid
$12.75 B
2025 Buybacks
$12.08 B
Q2 2026 OCF
$22.63 B
Q2 2026 CapEx
$4.54 B
Q2 2026 FCF
$18.10 B
Q2 2026 Dividends
$3.50 B
Q2 2026 Buybacks
$3.00 B
Dividend Per Quarter
$1.71
Gross Margin (TTM)
44.3%
EBITDA Margin
24.2%
Goodwill
$4.57 B
Retained Earnings
$212.6 B
Fair Value Estimate
$190–$205/share
Strengths
Concerns
Chevron Corporation is a mega-cap integrated oil and gas company with a $405B market cap trading on NYQ, operating across upstream E&P, refining, chemicals, and emerging low-carbon investments with major exposure to the Permian Basin and the newly acquired Guyana Stabroek Block. The company demonstrated exceptional Q2 2026 performance with $67.2B revenue and $12.07B net income (EPS $6.11), while TTM figures show $209.4B revenue, $20.6B net income, and $21.93B free cash flow, supported by a 3.44% dividend yield and 37 consecutive years of dividend growth. With forward P/E of 14.20, PEG of 0.91, and ~6.3% total shareholder yield, the stock offers a compelling combination of income and value, though it appears fairly valued to modestly overvalued at current levels near $207 based on estimated fair value of $190-$205/share.
Macro: Fed on hold (96% probability of zero cuts in 2026 per Polymarket, $8.8M volume) supports firm USD but signals non-collapsing economy. Labor market weakening (weak September jobs report) raises demand-destruction concerns for refined products. Recession probability low at 8% by end-2026 ($2.3M Polymarket volume). Geopolitical risk premium embedded: 14% US-Iran conflict probability ($72M Polymarket volume); OPEC cohesion high (90% no exits, only 4% dissolve probability). Equity market bifurcation: Nasdaq hitting highs while Dow slips, creating mild relative drag on CVX as Dow component.